Thomas Reiser/X
Aug 28, 2025, 18:38
ISTH Survey: APS Diagnosis and Antithrombotic Treatment in Acute Ischemic Cardiac Disease
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), shared a post on X:
”Your expertise is requested.
Take this survey from the ISTH SSC Subcom. on Lupus Anticoagulant/Antiphospholipid Antibodies on APS diagnosis and antithrombotic treatment in patients with acute ischemic cardiac disease to assess current clinical practices.”
Stay updated with Haemostasis Today.
-
Mar 6, 2026, 14:35Selma Turkovic: Announcing the New Date for the WBIT Webinar
-
Mar 6, 2026, 14:33Caitlin Raymond: Why Transfusion Medicine Should Be Looped in Early in Transfusion Reactions
-
Mar 6, 2026, 14:28Peter Kouides: Why Raising the Ferritin Cutoff in Women Matters
-
Mar 6, 2026, 12:45Gajendra Singh Sandhu: Essential Brain Health Tips to Prevent Stroke
-
Mar 6, 2026, 12:41Jacqui McCallum: A Call to Action from the WSO 2025 Scientific Statement on Sex and Gender Differences in Stroke
-
Mar 6, 2026, 12:35Pipin Kojodjojo: How to Treat a Combination of Pulmonary Embolism and an Active Intracranial Hemorrhage?
-
Mar 6, 2026, 12:11Mathangi Kumar: Why People with Hemophilia Are Ending Up in the ER for Dental Emergencies
-
Mar 6, 2026, 12:06Marieke Kruip: Closing the Gender Gap in Anticoagulation for Mechanical Heart Valves
-
Mar 6, 2026, 12:02Wolfgang Miesbach: Targeted Anti-TFPI Therapy with Marstacimab Supports Joint Stability in Hemophilia A